Wednesday, June 5, 2019

Drug companies decided not to pursue Enbrel for Alzheimer's


Enbrel(etanercept) is the drug that Dr. Tobinick(19 posts) seems to have never even entertained trying to get his uses of etanercept  for stroke tested in a clinical trial.
Here is an analysis of Dr. Tobinick's use of Enbrel for whatever.

Enbrel for Stroke and Alzheimer’s

 
CHICAGO, June 5, 2019 — “Any science that has promise for Alzheimer’s disease and other dementias and is not genuinely pursued, or shared with the research community, does a disservice to the millions of individuals facing the disease today and in the future. Alzheimer's is a personally devastating and fatal disease, the sixth leading cause of death in the United States, with the number of people impacted by the disease increasing daily. No stone should be left unturned. The expectation of the Alzheimer’s Association and our millions of constituents is that every possible path is pursued thoroughly and aggressively with people living with the disease as a priority.”

— Maria C. Carrillo, Ph.D., chief science officer, Alzheimer’s Association

No comments:

Post a Comment